reference/5257885

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5257885

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	3061
issn	1538-8514 1535-7163
issueIdentifier	12
pageRange	3049-3061
publicationName	Molecular Cancer Therapeutics
startingPage	3049
bibliographicCitation	Yeom SY, Nam DH, Park C. RRAD promotes EGFR-mediated STAT3 activation and induces temozolomide resistance of malignant glioblastoma. Mol Cancer Ther. 2014 Dec;13(12):3049–61. doi: 10.1158/1535-7163.mct-14-0244. PMID: 25313011.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_830c947ee3d22a580ddca2fbd9a01c16 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57801140bce7cf8e36efac2484a3c58a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80d18a46cc2f4d0e35878a6bdffcb23b
date	2014-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/1535-7163.mct-14-0244 https://pubmed.ncbi.nlm.nih.gov/25313011
isPartOf	https://portal.issn.org/resource/ISSN/1538-8514 https://portal.issn.org/resource/ISSN/1535-7163 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	RRAD Promotes EGFR-Mediated STAT3 Activation and Induces Temozolomide Resistance of Malignant Glioblastoma
discusses	http://id.nlm.nih.gov/mesh/M0229085 http://id.nlm.nih.gov/mesh/M0136562 http://id.nlm.nih.gov/mesh/M0028268 http://id.nlm.nih.gov/mesh/M0005636 http://id.nlm.nih.gov/mesh/M0027924 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0224154
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018906Q000494 http://id.nlm.nih.gov/mesh/D003606Q000031 http://id.nlm.nih.gov/mesh/D050796Q000378 http://id.nlm.nih.gov/mesh/D018631Q000378 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D005909Q000378 http://id.nlm.nih.gov/mesh/D066246Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003606Q000494 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D055550 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018874 http://id.nlm.nih.gov/mesh/D015972 http://id.nlm.nih.gov/mesh/D002467Q000378 http://id.nlm.nih.gov/mesh/D018631Q000235 http://id.nlm.nih.gov/mesh/D000077204 http://id.nlm.nih.gov/mesh/D005909Q000401 http://id.nlm.nih.gov/mesh/D005909Q000473 http://id.nlm.nih.gov/mesh/D005909Q000235 http://id.nlm.nih.gov/mesh/D021381 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D011992Q000378 http://id.nlm.nih.gov/mesh/D002471Q000235 http://id.nlm.nih.gov/mesh/D002471Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_109d3e37913d59192146607c78c79a5e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_95858a7883c26280557b4db19d204c39 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_eeaf52dd577984e6d2c606adb68025d9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_132a8504e7423e57e5565c4615cd0cd2 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7099 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e3f36829af973723868172cfd2e51411 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8ba5eb727d3d20b14dc78be9075efd51 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9476 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7838 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918763 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4a35e0c5f9bb06b7e75beec86210644d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b8d4ac94525254b9da5df5208e94cd01 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7464 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8411 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6236 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6774 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1956

Total number of triples: 76.